Apnar Pharma Private Limited

Apnar Pharma Private Limited - pharma in Padra, Gujarat, India. FY 2026 financials and compliance.
CIN U73100GJ2014PTC081520 Incorporated 12 December 2014 ROC Ahmedabad HQ Padra, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹14.22 Cr
▼ 48.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹7.6 Cr
Registered with MCA
Paid-up capital
₹7.55 Cr
Issued & subscribed
Open charges
₹50.35 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
95
Latest available

About Apnar Pharma Private Limited

Data last updated: 29 December 2025

Apnar Pharma Private Limited is a private limited company based in Padra, Gujarat, India, a subsidiary of Apnar Pharma Lp. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 12 December 2014, the company has been in operation for over 12 years.

Registered with ROC Ahmedabad under CIN U73100GJ2014PTC081520.

Capital: an authorised share capital of ₹7.6 Cr and a paid-up capital of ₹7.55 Cr. Formerly known as Apnar Research Pharma Private Limited. It is led by directors including Umesh Patel and Dharmesh Bhikhabhai Patel.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Block No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.22 Cr, a decline of 48% compared to the previous year.

The company has a workforce of approximately 95 employees as per the latest available data. It operates as a subsidiary of Apnar Pharma Lp.

The company is associated with 1 brand - Apnar Pharma. As per MCA filings, the company has open charges of ₹50.35 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apnarpharma.com.

Company Details of Apnar Pharma Private Limited
CIN U73100GJ2014PTC081520
Registration Number 081520
Incorporation Date 12 December 2014
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Apnar Pharma Lp
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Block No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430
  • Industry
    Pharma, Drug Formulation & Development
Company report
Apnar Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Apnar Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Apnar Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Apnar Pharma Private Limited

Apnar Pharma Private Limited operates one associated brand: Apnar Pharma. These brands represent Apnar Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. apnarpharma.com

Competitors & Alternatives of Apnar Pharma Private Limited

Brands and companies operating in the same space as Apnar Pharma Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 7 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
Aenova Group Aenova Group CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. Starnberg, Germany, Germany 2008
Zambon Pharma Zambon Pharma APIs and finished drugs are developed and manufactured in pharmaceuticals. Bresso, Italy, Italy 1906
Leukocare Leukocare Proprietary stabilizing solutions for biologics formulations are developed. Munich, Germany, Germany 2003

Business Activity of Apnar Pharma Private Limited

Apnar Pharma Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Apnar Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Apnar Pharma Private Limited

Apnar Pharma Private Limited is audited by SHAH SANGHVI & ASSOCIATES for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SHAH SANGHVI & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Apnar Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Apnar Pharma Private Limited

Apnar Pharma Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Umesh Patel Director 25 Feb 2015 11 Years 5 Months Current
Dharmesh Bhikhabhai Patel Director 24 Jan 2015 11 Years 6 Months Current
Swapnil Kantibhai Patel Director 12 Dec 2014 11 Years 8 Months Current

Financials of Apnar Pharma Private Limited FY 2025 filings available

Apnar Pharma Private Limited reported revenue of ₹14.22 Cr (down 48.00% YoY) for FY 2025.

Revenue · FY 2025
₹14.22 Cr ▼ 48.00%
Premium access

Ten-year financial statements for Apnar Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Apnar Pharma Private Limited

Premium access

Shareholding and ownership data for Apnar Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Apnar Pharma Private Limited

Open charges
₹50.35 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹30.49 Cr
Hdfc Bank Limited₹19.87 Cr
Latest charge details
DateLenderAmountStatus
29 Jun 2022 Others ₹7.5 Cr Open
09 Dec 2021 Others ₹83.38 Lakh Open
24 Aug 2020 Others ₹1.66 Cr Open
26 May 2020 Hdfc Bank Limited ₹19.87 Cr Open
16 Dec 2017 Others ₹11.49 Cr Open

Total charge records: 6 View all charges

Employees and EPFO Compliance at Apnar Pharma Private Limited

Apnar Pharma Private Limited has a workforce of 95 employees as of Feb 27, 2025.

Employee count
95
Active EPFO establishments
1
Employee growth
-28.03%
Premium access

Employee and EPFO history for Apnar Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Apnar Pharma Private Limited

Premium access

GST registrations and filing compliance for Apnar Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Apnar Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Apnar Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Apnar Pharma Private Limited

Premium access

MSME payment history for Apnar Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Apnar Pharma Private Limited

Premium access

Corporate group structure for Apnar Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Apnar Pharma Private Limited

Premium access

MCA filings and documents for Apnar Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Apnar Pharma Private Limited

Activity
30 Sep 2025
Apnar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Apnar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
25 Jul 2023
A charge with Hdfc Bank Limited of Rs. 19.87 Cr registered on 26 May 2020 with Charge ID 100347326 was modified on 25 Jul 2023.
Charges
29 Jun 2022
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100595339 was registered on 29 Jun 2022.
Charges
25 Feb 2022
A charge with Others of Rs. 11.49 Cr registered on 16 Dec 2017 with Charge ID 100145635 was modified on 25 Feb 2022.
Charges
09 Dec 2021
A charge with Others amounted to Rs. 0.83 Cr with Charge ID 100519438 was registered on 09 Dec 2021.

Frequently Asked Questions about Apnar Pharma Private Limited

Apnar Pharma Private Limited is an active private limited company in the pharma sector based in Padra, Gujarat, India. It was incorporated on 12 December 2014 (12+ years old) and is registered under CIN U73100GJ2014PTC081520. The company has 95 employees.

Apnar Pharma Private Limited reported revenue of ₹14.22 Cr for FY 2025 (down 48.00% YoY).

The current directors of Apnar Pharma Private Limited are:

The primary industry of Apnar Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Apnar Pharma Private Limited can be reached at the registered office: Block No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430, or through the website apnarpharma.com.

The authorised capital is ₹7.6 Cr, and the paid-up capital is ₹7.55 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available